김지영 프로필 사진

김지영

Kim, Ji Young

연구소

암연구소

Scopus

자료 필터

자료유형

발행연도

2015 ~ 2026
2015 2026

키워드

언어

선택된 필터

  • article
  • conference
  • book

전체 36건 중 1번부터 10번까지의 결과를 표시합니다.

2026
Article

Ebastine targets HER2/HER3 signaling and cancer stem cell traits to overcome trastuzumab resistance in HER2-positive breast cancer

  • 2026-04
  • International Journal of Molecular Medicine
  • Demetrios A. Spandidos Ed. & Pub.
Article

C‑terminal HSP90 inhibitor NCT‑58 impairs the cancer stem‑like phenotype and enhances chemotherapy efficacy in TNBC

  • 2026-01
  • Oncology Reports
  • Demetrios A. Spandidos Ed. & Pub.
2025
Article

Pitavastatin is a novel Mcl-1 inhibitor that overcomes paclitaxel resistance in triple-negative breast cancer

  • 2025-12
  • Experimental Hematology & Oncology
  • BioMed Central
2024
Article

The HSP90 inhibitor HVH-2930 exhibits potent efficacy against trastuzumab-resistant HER2-positive breast cancer

  • 2024-03
  • Theranostics
  • Ivyspring International Publisher
2023
Article

Suppression of TNBC metastasis by doxazosin, a novel dual inhibitor of c-MET/EGFR

  • 2023-11
  • Journal of Experimental and Clinical Cancer Research
  • BioMed Central
Article

Ebastine impairs metastatic spread in triple-negative breast cancer by targeting focal adhesion kinase

  • 2023-05
  • Cellular and Molecular Life Sciences
  • Springer Nature
Article

A dual-action niclosamide-based prodrug that targets cancer stem cells and inhibits TNBC metastasis

  • 2023-05
  • Proceedings of the National Academy of Sciences of the United States of America
  • National Academy of Sciences
Article

Cutting Off H plus Leaks on the Inner Mitochondrial Membrane: A Proton Modulation Approach to Selectively Eradicate Cancer Stem Cells

  • 2023-03
  • Journal of the American Chemical Society
  • American Chemical Society
2022
Article

A synchronized dual drug delivery molecule targeting cancer stem cells in tumor heterogeneity and metastasis

  • 2022-10
  • Biomaterials
  • Pergamon Press Ltd.
Article

beta-Escin overcomes trastuzumab resistance in HER2-positive breast cancer by targeting cancer stem-like features

  • 2022-09
  • Cancer Cell International
  • BioMed Central
1234 끝